The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.

(Yicai) Dec. 31 -- Shares of Everest Medicines dropped after the Chinese biopharmaceutical company's immunoglobulin A ...

Health policy is not always a straightforward topic of discussion. There are many aspects to the complex health care system ...

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

Discover how a traditional Chinese herbal mix showed better results in treating a common kidney disease compared to commonly ...

New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...

Making medical policy based on racial stereotypes harmed all Black Americans waiting for a kidney. This lawsuit is brought by ...

In the past decade, we have seen tremendous advances in the prevention, treatment and management of chronic kidney disease ...

Q: What are kidney stones, and how do I prevent them? Kidney stones are common, impacting approximately one in five men and ...

Led by Professor Takaaki Abe at Tohoku University Graduate School of Medicine, the team discovered that a medicine usually ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

For patients who once traveled long distances for treatment, the seven-machine centre ends grueling journeys and exorbitant ...